Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prostatic adenocarcinoma--still a diagnostic problem].

B Helpap1

  • 1Institut für Pathologie, Hegau-Bodensee-Hochrhein-Kliniken, Standort Singen.

Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|August 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Grading of prostate cancer].

Der Pathologe·2016
Same author

[Prostate cancer. Part 2: Review of the various tumor grading systems over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)].

Der Pathologe·2016
Same author

[Prostate cancer. Part 1: Review of cell kinetics over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)].

Der Pathologe·2016
Same author

[Wolfgang Oehmichen : 11.11.1923 - 27.09.2014].

Der Pathologe·2015
Same author

Improving the reproducibility of the Gleason scores in small foci of prostate cancer--suggestion of diagnostic criteria for glandular fusion.

Pathology oncology research : POR·2011
Same author

[Importance of second opinions on histology of prostate biopsy specimens].

Der Pathologe·2011

Diagnosing small prostate cancers can be challenging. A new marker, alpha-methyl CoA-racemase (P504S), combined with P63, helps confirm diagnoses in suspicious prostate biopsies, avoiding repeat procedures.

Area of Science:

  • Uropathology
  • Immunohistochemistry
  • Cancer Biomarkers

Context:

  • Diagnosing small prostate adenocarcincinomas in biopsies presents challenges due to ambiguous histological features.
  • Suspicious findings include indistinct basal cell layers and lack of specific markers like cytokeratin clone 34betaE12 or p63.
  • Difficulty in diagnosis leads to repeat biopsies, causing patient anxiety and delayed treatment.

Purpose:

  • To evaluate the utility of alpha-methyl CoA-racemase (P504S) as a diagnostic marker for prostate carcinoma.
  • To assess the combined diagnostic performance of P504S and P63 in challenging prostate biopsy cases.
  • To reduce the rate of 'suspicious' diagnoses and the need for repeat prostate biopsies.

Summary:

  • Prostate adenocarcinoma diagnosis can be difficult in small biopsies with atypical features.

Related Experiment Videos

  • Alpha-methyl CoA-racemase (P504S) is overexpressed in prostate cancer cells.
  • Combining P504S (positive) with P63 (negative) immunhistochemistry aids in diagnosing 35-45% of suspicious prostate biopsies.

    • Impact:

    • Enables definitive diagnosis in a significant proportion of previously indeterminate prostate biopsies.
    • Reduces the need for repeat biopsies, leading to timely treatment initiation.
    • Improves patient management by providing clear diagnostic and therapeutic pathways.